pubmed-article:1327583 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:1327583 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:1327583 | lifeskim:mentions | umls-concept:C0012634 | lld:lifeskim |
pubmed-article:1327583 | lifeskim:mentions | umls-concept:C0439660 | lld:lifeskim |
pubmed-article:1327583 | lifeskim:mentions | umls-concept:C0521451 | lld:lifeskim |
pubmed-article:1327583 | lifeskim:mentions | umls-concept:C0007258 | lld:lifeskim |
pubmed-article:1327583 | lifeskim:mentions | umls-concept:C0242485 | lld:lifeskim |
pubmed-article:1327583 | lifeskim:mentions | umls-concept:C1261322 | lld:lifeskim |
pubmed-article:1327583 | lifeskim:mentions | umls-concept:C1158366 | lld:lifeskim |
pubmed-article:1327583 | lifeskim:mentions | umls-concept:C0185125 | lld:lifeskim |
pubmed-article:1327583 | lifeskim:mentions | umls-concept:C0750491 | lld:lifeskim |
pubmed-article:1327583 | pubmed:issue | 3 | lld:pubmed |
pubmed-article:1327583 | pubmed:dateCreated | 1992-11-18 | lld:pubmed |
pubmed-article:1327583 | pubmed:abstractText | We describe an improved radio-enzymatic method for the measurement of carnitine, short-chain acyl-carnitine and long-chain acyl-carnitine in plasma and tissue. An internal standard, hexadecanoyl-[CH3-3H]-carnitine was synthesised and used to improve the determination of long-chain acyl-carnitine. The between and within batch precisions were 10.4 and 7%, respectively. Control data for neonates, infants, children and adults in the fed and fasted state are documented. In addition we confirm the hypocarnitinaemia associated with pregnancy. Patients with medium-chain acyl-CoA dehydrogenase deficiency were studied during episodes of hypoglycaemia. In both fasted controls and patients there were high concentrations of short-chain acyl-carnitine, however in the latter group there were also low concentrations of free carnitine. We suggest that the monitoring of plasma carnitine and its derivatives is a useful adjunct to the investigation of children suspected to suffer from inherited disorders of mitochondrial beta-oxidation. We also describe a sample preparation procedure suitable for high performance liquid chromatographic analysis of specific acyl-carnitines from urine, plasma and tissue homogenates. The recoveries of acetyl-carnitine, octanoyl-carnitine and hexadecanoyl carnitine from urine were 101.5, 95 and 91% and from plasma 99.5, 91.5 and 85.5%, respectively. Acyl-carnitines (C2-C16) were analysed as their p-bromophenacyl derivatives by reverse-phase high performance liquid chromatography using a ternary gradient of acetonitrile/water/triethylamine phosphate. We report ten patients who excreted octanoyl-carnitine, hexanoyl-carnitine and in some cases a small amount of decanoyl-carnitine. In most of these cases suberylglycine and dicarboxylic acids were also detected by GC/MS. We had access to cultured fibroblasts from five of these patients and were able to demonstrate medium-chain acyl-CoA dehydrogenase deficiency by direct enzyme assay. | lld:pubmed |
pubmed-article:1327583 | pubmed:language | eng | lld:pubmed |
pubmed-article:1327583 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1327583 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:1327583 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1327583 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1327583 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1327583 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1327583 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1327583 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:1327583 | pubmed:month | May | lld:pubmed |
pubmed-article:1327583 | pubmed:issn | 0009-8981 | lld:pubmed |
pubmed-article:1327583 | pubmed:author | pubmed-author:Aynsley-Green... | lld:pubmed |
pubmed-article:1327583 | pubmed:author | pubmed-author:BartlettKK | lld:pubmed |
pubmed-article:1327583 | pubmed:author | pubmed-author:LeonardJ VJV | lld:pubmed |
pubmed-article:1327583 | pubmed:author | pubmed-author:JacksonSS | lld:pubmed |
pubmed-article:1327583 | pubmed:author | pubmed-author:TurnbullD MDM | lld:pubmed |
pubmed-article:1327583 | pubmed:author | pubmed-author:BhuiyanA KAK | lld:pubmed |
pubmed-article:1327583 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:1327583 | pubmed:day | 15 | lld:pubmed |
pubmed-article:1327583 | pubmed:volume | 207 | lld:pubmed |
pubmed-article:1327583 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:1327583 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:1327583 | pubmed:pagination | 185-204 | lld:pubmed |
pubmed-article:1327583 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:1327583 | pubmed:meshHeading | pubmed-meshheading:1327583-... | lld:pubmed |
pubmed-article:1327583 | pubmed:meshHeading | pubmed-meshheading:1327583-... | lld:pubmed |
pubmed-article:1327583 | pubmed:meshHeading | pubmed-meshheading:1327583-... | lld:pubmed |
pubmed-article:1327583 | pubmed:meshHeading | pubmed-meshheading:1327583-... | lld:pubmed |
pubmed-article:1327583 | pubmed:meshHeading | pubmed-meshheading:1327583-... | lld:pubmed |
pubmed-article:1327583 | pubmed:meshHeading | pubmed-meshheading:1327583-... | lld:pubmed |
pubmed-article:1327583 | pubmed:meshHeading | pubmed-meshheading:1327583-... | lld:pubmed |
pubmed-article:1327583 | pubmed:meshHeading | pubmed-meshheading:1327583-... | lld:pubmed |
pubmed-article:1327583 | pubmed:meshHeading | pubmed-meshheading:1327583-... | lld:pubmed |
pubmed-article:1327583 | pubmed:meshHeading | pubmed-meshheading:1327583-... | lld:pubmed |
pubmed-article:1327583 | pubmed:meshHeading | pubmed-meshheading:1327583-... | lld:pubmed |
pubmed-article:1327583 | pubmed:meshHeading | pubmed-meshheading:1327583-... | lld:pubmed |
pubmed-article:1327583 | pubmed:meshHeading | pubmed-meshheading:1327583-... | lld:pubmed |
pubmed-article:1327583 | pubmed:meshHeading | pubmed-meshheading:1327583-... | lld:pubmed |
pubmed-article:1327583 | pubmed:meshHeading | pubmed-meshheading:1327583-... | lld:pubmed |
pubmed-article:1327583 | pubmed:meshHeading | pubmed-meshheading:1327583-... | lld:pubmed |
pubmed-article:1327583 | pubmed:year | 1992 | lld:pubmed |
pubmed-article:1327583 | pubmed:articleTitle | The measurement of carnitine and acyl-carnitines: application to the investigation of patients with suspected inherited disorders of mitochondrial fatty acid oxidation. | lld:pubmed |
pubmed-article:1327583 | pubmed:affiliation | Human Metabolism Research Centre Department of Clinical Biochemistry, Medical School, University of Newcastle upon Tyne, UK. | lld:pubmed |
pubmed-article:1327583 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:1327583 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1327583 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1327583 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1327583 | lld:pubmed |